Pharma & Biotech Mergers & Acquisitions News
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Today's issue
Refine Search
Latest Mergers & Acquisitions News & Features
Generics
US drugmaker Lannett Company has signed a definitive agreement to acquire privately held Silarx Pharmaceuticals and a related real estate entity, a manufacturer and marketer of liquid generic pharmaceutical products. 18 May 2015
Generics
Ireland-headquartered Endo International has entered into a definitive agreement under to acquire privately-held Par Pharmaceutical from private investment firm TPG in a transaction valued at around $8.05 billion, including assumption of Par debt. 18 May 2015
Generics
Indian drugmaker Lupin said today that it has acquired a100% equity stake in Brazil-based pharma company Medquímica Indústria Farmacêutica, subject to certain closing conditions. 14 May 2015
Generics
US drugmaker Endo International has acquired a broad portfolio of branded and generic injectable and established products from a subsidiary of South Africa’s leading pharma company Aspen Holdings. 11 May 2015
Generics
Germany-based BASF says it plans to focus its pharmaceutical ingredients and services business within the Nutrition & Health division on its core expertise in pharmaceutical excipients. 7 May 2015
Generics
Netherlands-incorporated generics drugmaker Mylan has for a second time raised its offer price for smaller Ireland-based rival Perrigo. 29 April 2015
Generics
Indian drugmaker Aurobindo Pharma has sold its step down subsidiary Aurobindo Pharma Australia, with operations in Australia and New Zealand, to privately-held Eris Pharmaceuticals. 14 April 2015
Generics
Indian pharma company Cipla has informed the Bombay Stock Exchange that its UK subsidiary has entered into a definitive agreement to acquire a 100% stake in Duomed Produtos Farmaceuticos of Brazil. 10 April 2015
Generics
Privately-held US generics drugmaker Amneal Pharmaceuticals and the Australian subsidiary of Actavis have signed a binding letter of intent which provides that Amneal intends to acquire substantially all of Actavis’ in-country generic pharmaceuticals business. 31 March 2015
Generics
Indian generic drugmaker Sun Pharmaceutical Industries has at last completed the merger of Ranbaxy Laboratories today, and begins the integration of Ranbaxy's business. 25 March 2015
Generics
Canadian pharma and medical devices company Concordia Healthcare Corp has entered into a definitive asset purchase agreement to acquire substantially all of the commercial assets of privately held Swiss specialty drug firm Covis Pharma Sàrl and Covis Injectables Sàrl $1.2 billion in cash. 10 March 2015
Generics
Ireland-headquartered generics major Actavis has reached a definitive agreement with TPG, the global private investment firm, to divest to TPG the business currently known as Aptalis Pharmaceutical Technologies (Pharmatech). 13 February 2015
Generics
Julphar, the largest Emirati pharmaceutical company, has acquired a majority stake in Bangladesh drugmaker RAK Pharmaceuticals for $9.5 million, marking its entry into the region and an expansion of its footprint in Asia. 13 February 2015
Generics
Indian drugmakers Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories have agreed to divest Ranbaxy’s interests in generic minocycline tablets in order to settle US Federal Trade Commission charges that Sun’s $4 billion proposed acquisition of Ranbaxy would likely be anticompetitive. 1 February 2015
Generics
US generic drugmaker Mylan and US drugmaker Abbott Laboratories have revised the pricing terms of their generics arrangement agreed in July. 23 October 2014
Generics
US generic drugmaker Impax Laboratories saw its shares leap 11.2% to $26.52 in pre-market trading today, as the company revealed plans for two acquisitions. 9 October 2014
Generics
With over $50 billion worth of drugs set to go off patent over the next two years in the USA, Indian pharmaceutical companies are stepping up to the plate, loosening their purse strings and spending more on capital expenditure (capex), reports The Pharma Letter’s India correspondent. 28 August 2014
Generics
Moody's Investors Service says that India's pharmaceutical market will continue to grow in the double digits; a rate which is more favorable than most other markets for the industry. However, drug companies in the country could face higher debt levels, as the pharmaceutical sector in India grows, resulting in mergers and acquisitions. 25 August 2014
Generics
The deal between Indian generics company Sun Pharmaceutical Industries which acquired fellow Indian drug maker Ranbaxy Laboratories in April has come before the Competition Commission of India. 11 August 2014
Generics
The US Federal Trade Commission revealed yesterday that US generics drugmaker Akorn has agreed to sell its rights to develop, manufacture, and market the generic injectable tuberculosis drug, rifampin, in order to settle FTC charges that Akorn’s proposed acquisition of VersaPharm and its parent company, VPI Holdings, would likely be anticompetitive. 5 August 2014
Generics
Aspire Pharma, a UK-based niche generics business, has announced the acquisition of all assets from Canute Pharma, further expanding its product range. 4 October 2024
Generics
Viatris has announced that the antitrust division of the US Department of Justice (DOJ) has concluded its investigation into Mylan and its former president, Rajiv Malik. 3 July 2024
Generics
An activist investor has renewed its effort to prevent Taro Pharmaceutical from accepting a buyout bid from Sun Pharmaceutical. 24 April 2024
Generics
Generic drugmaker Apotex has reached an agreement to acquire fellow Canada-based Searchlight Pharma. 5 April 2024
Generics
KELIX bio, an emerging markets biopharmaceuticals platform, has been sold to Mubadala Investment Company, an Abu Dhabi investor with over $276 billion in assets under management. 25 March 2024
Generics
Generic drugmaker Aspire Pharma today announced the successful completion of its acquisition of fellow UK-based Cenoté Pharma, in continuation of its strong organic growth. 11 March 2024
Generics
In a bid to focus on growth and innovation, Israeli generics drugmaker Teva Pharmaceutical is to hive off its active pharmaceutical ingredient (API) business. 1 February 2024
Generics
Sun Pharmaceutical Industries of India announced its intention to acquire all outstanding shares of US generics drugmaker Taro Pharmaceutical Industries at a price of $43 per share in cash, the companies announced. 19 January 2024
Generics
Taiwan’s Bora Pharmaceuticals is to acquire Upsher-Smith Laboratories, a US generics manufacturer. 17 January 2024
Generics
South Africa's largest drugmaker Aspen Pharmacare has announced an agreement with newly-independent generics drugmaker Sandoz, related to its Chinese business. 7 December 2023
Generics
Portuguese contract development and manufacturing organization (CDMO) Hovione has acquired the start-up ExtremoChem for an undisclosed amount. 20 November 2023
Generics
The Indian pharma and healthcare sector has witnessed a 298% jump in deals during the third quarter of 2023 compared to the same period last year. 8 November 2023
Generics
A confluence of factors is creating a conducive environment for mergers and acquisitions (M&As) to pick up pace in India. 23 October 2023
Generics
USA-based drugmaker Viatris has announced a series of divestitures as part of a strategy to narrow the company’s focus. 3 October 2023
Generics
Indian drugmaker Glenmark Pharmaceuticals has entered into a definitive agreement with Nirma Limited to divest a 75% stake in its subsidiary, Glenmark Life Sciences Limited (GLS), which focuses on producing active pharmaceutical ingredients (APIs). 22 September 2023
Generics
Shares of Hyderabad, India-headquartered Suven Pharmaceuticals hit a fresh 52-week high on the bourses after the Indian government gave the green signal to foreign direct investment (FDI) of up to $1.15 billion by drug major Cyprus-based Berhyanda. 19 September 2023
Generics
Several international investors and fund managers have expressed an interest in investing in the Indian pharmaceutical and biotechnology sectors, underlining the need to establish a platform to facilitate the transition of global capital flows into the domestic economy. 14 April 2023
Generics
In what could well be India's biggest pharma deal, China's Fosun Pharma-owned Gland Pharma is on the block. A number of private equity firms have been approached, including Baring Private Equity, Bain Capital, Blackstone, Carlyle, and KKR. 19 December 2022
Generics
Generics major Viatris yesterday said it intends to create an ophthalmology franchise by acquiring two companies, Oyster Point Pharma (Nasdaq: OYST) and Famy Life Sciences. 8 November 2022
Generics
Private equity firm SK Capital Partners has entered into a deal to acquire Apotex Pharmaceutical Holdings, a Canada-based generic drugmaker with products across all major therapeutic areas for patients around the world. 29 September 2022
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze